TCV Trust & Wealth Management Inc. Decreases Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

TCV Trust & Wealth Management Inc. lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.8% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 41,483 shares of the healthcare conglomerate’s stock after selling 763 shares during the period. UnitedHealth Group makes up approximately 2.0% of TCV Trust & Wealth Management Inc.’s holdings, making the stock its 11th largest holding. TCV Trust & Wealth Management Inc.’s holdings in UnitedHealth Group were worth $21,727,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. NewSquare Capital LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter worth about $25,000. Marshall & Sterling Wealth Advisors Inc. bought a new stake in shares of UnitedHealth Group in the fourth quarter worth about $26,000. Hurley Capital LLC bought a new stake in shares of UnitedHealth Group in the fourth quarter worth about $28,000. Aster Capital Management DIFC Ltd bought a new stake in shares of UnitedHealth Group in the fourth quarter worth about $30,000. Finally, Promus Capital LLC bought a new stake in UnitedHealth Group during the 4th quarter valued at approximately $32,000. 87.86% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on the company. Piper Sandler cut their price objective on UnitedHealth Group from $552.00 to $353.00 and set an “overweight” rating on the stock in a research report on Tuesday, June 3rd. Raymond James Financial cut UnitedHealth Group from a “strong-buy” rating to a “market perform” rating in a research report on Wednesday, May 14th. TD Cowen cut UnitedHealth Group from a “buy” rating to a “hold” rating and set a $308.00 price objective on the stock. in a research report on Monday, May 19th. Morgan Stanley dropped their price target on UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a research report on Wednesday, May 14th. Finally, Royal Bank Of Canada lowered their price objective on UnitedHealth Group from $525.00 to $355.00 and set an “outperform” rating for the company in a research note on Friday, May 16th. One investment analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have issued a buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus target price of $415.57.

Insider Activity at UnitedHealth Group

In other news, Director Timothy Patrick Flynn acquired 1,533 shares of UnitedHealth Group stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the transaction, the director now directly owns 6,033 shares of the company’s stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this link. Also, CEO Patrick Hugh Conway sold 589 shares of the stock in a transaction dated Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer now directly owns 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders acquired 109,408 shares of company stock valued at $31,607,768. Insiders own 0.28% of the company’s stock.

UnitedHealth Group Price Performance

Shares of UNH opened at $308.85 on Friday. UnitedHealth Group Incorporated has a 1-year low of $248.88 and a 1-year high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71. The firm has a market cap of $280.17 billion, a PE ratio of 12.93, a P/E/G ratio of 1.43 and a beta of 0.44. The firm has a fifty day simple moving average of $336.21 and a two-hundred day simple moving average of $454.51.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a return on equity of 26.29% and a net margin of 5.39%. The business had revenue of $109.58 billion during the quarter, compared to analysts’ expectations of $111.56 billion. During the same quarter in the previous year, the company posted $6.91 EPS. On average, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a dividend yield of 2.86%. The ex-dividend date of this dividend was Monday, June 16th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.10. UnitedHealth Group’s dividend payout ratio is 37.02%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.